Skip to content

Serotonin: all studies

Page 301 of 400: studies 3,001 to 3,010 of 3,999, newest first. Back to the serotonin overview

Research

Is Kambô psychoactive? Acute and subacute effects of the secretion of the Giant Maki Frog (Phyllomedusa bicolor) on human consciousness

bioRxiv (Cold Spring Harbor Laboratory) July 24, 2020 Timo Torsten Schmidt, Simon Reiche, Caroline L. C. Hage et al. preprint

ABSTRACT Kambô is the name for the secretion of the Giant Leaf Frog (Phyllomedusa bicolor) containing a plethora of bioactive peptides. Originally, it is ritually used by different ethnicities from the Amazon basin as a remedy against bad luck in hunting. In the last twenty years, Kambô has spread to Western urban centers, often associated with the use of ayahuasca. Anecdotal reports claim...

Modulatory effects of ayahuasca on personality structure in a traditional framework

Psychopharmacology July 23, 2020 Nige Netzband, Simon Ruffell, Sabriya Linton et al. 56 citations

Abstract Abstract Ayahuasca is a psychoactive plant brew containing dimethyltryptamine (DMT) and monoamine oxidase inhibitors (MAOIs). It originates from the Amazon basin, where it is used primarily for ceremonial purposes. Ayahuasca tourists are now entering certain communities seeking alternative physical or psychological healing, as well as spiritual growth. Rationale Recent evidence has...

4 Psychedelics: therapeutic mechanisms

Journal of Neurology, Neurosurgery, and Psychiatry July 20, 2020 Robin Carhart-Harris

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has designed and/or carried out brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and an ongoing study...

DOI: 10.1136/jnnp-2020-bnpa.4 (opens in new tab) Psilocybin Hallucinogen Psychoanalysis Psychotherapist

Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.

Behavioural Brain Research July 9, 2020 Tomohisa Mori, Naoki Uzawa, Daiki Masukawa et al.

Orexinergic neurons, which are closely associated with narcolepsy, regulate arousal and reward circuits through the activation of monoaminergic neurons. Psychostimulants as well as 5-HT-related compounds have potential in the treatment of human narcolepsy. Previous studies have demonstrated that orexin receptor antagonists as well as orexin deficiencies affect the pharmacological effects of...

Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential

Plants July 9, 2020 Beatriz Werneck Lopes Santos, Regina Célia de Oliveira, Júlia Sonsin‐oliveira et al. 32 citations

Ayahuasca is a psychoactive infusion with a large pharmacological application normally prepared with Banisteriopsis caapi, which contains the monoamine oxidase inhibitors β-carbolines, and Psichotria virids, which contains the serotonin receptor agonist N,N dimethyltryptamine (DMT). The objectives of this study were to investigate the chemical profile of B. caapi and of ayahuasca collected in...

DOI: 10.3390/plants9070870 (opens in new tab) Ayahuasca Harmine Harmaline Malpighiaceae +4

Drinking to death: Hyponatraemia induced by synthetic phenethylamines.

Drug and Alcohol Dependence July 1, 2020 Ana Carolina Faria, Helena Carmo, Félix Carvalho et al.

Synthetic phenethylamines are widely abused drugs, comprising new psychoactive substances such as synthetic cathinones, but also well-known amphetamines such as methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Cathinones and amphetamines share many toxicodynamic mechanisms. One of their potentially life-threatening consequences, particularly of MDMA, is serotonin-mediated...

DOI: 10.1016/j.drugalcdep.2020.108045 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA, Ecstasy Serotonin syndrome Synthetic cathinone

Escalating low-dose Δ9 -tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats.

European Journal of Neuroscience July 2020 Nafsika Poulia, Foteini Delis, Charalampos Brakatselos et al.

Cannabinoid administration during adolescence affects various physiological processes, such as motor and affective response, cognitive-related functions and modulates neurotransmitter activity. Literature remains scant concerning the parallel examination of the effects of adolescent escalating low-dose Δ9 -tetrahydrocannabinol (Δ9 -THC) on the behavioral and plasticity profile of adult rats in...

DOI: 10.1111/ejn.14598 (opens in new tab) Full text (opens in new tab) Adult Behavioral analysis Cannabinoids Neuronal plasticity

Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats

Journal of Psychopharmacology July 1, 2020 Michael B. Gatch, Michael J Forster

Background: Synthetic cathinone derivatives are used as alternatives both for stimulant drugs such as cocaine and methamphetamine and for club drugs such as 3,4-methylenedioxymethamphetamine (MDMA), but little is known about their MDMA-like subjective effects. Methods In order to determine their similarity to MDMA, the discriminative stimulus effects of 10 pyrrolidinyl cathinones...

25C-NBOMe short characterisation

Forensic Toxicology July 1, 2020 Katarzyna Kamińska, Paweł Świt, Kamilla Malek

Abstract Purpose N-Methoxybenzyls, a group of toxic phenylethylamine derivatives of the 2C family compounds, are a new class of potent serotonin 5-HT2A receptor agonist hallucinogens with potential harmful effects. This study summarizes current state of knowledge of one of the most dangerous representative of this group—N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe). Due...

Psilocybin-assisted therapy and depression - a systematic review

Open Repository of the University of Porto (University of Porto) June 5, 2020 Rui Pedro Leal Andrade

Background: Psilocybin is a naturally occurring serotonin receptor agonist that can be, more commonly, found in the Psilocybe mushrooms. Consumed by indigenous cultures for millenia, Psilocybin, in the 1960s, was marketed in many countries under the trade name Indocybin, and, before its eventual ban, was safely used as an adjunct to psychotherapy in the treatment of depression and anxiety....